Brind.

Vector Science & Therapeutics Corp. Appoints Russell Starr as President

1 report, 1 independent Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Vector Science & Therapeutics Corp. announced that Russell Starr was appointed President of the company, effective October 5, 2026. Bill Jackson will continue to serve as Chief Executive Officer. As part of his appointment, Starr was granted 1,500,000 options that vest when the company's stock price reaches CAD $3.50, $4.50, and $5.50 or their USD equivalents over a 10-day volume-weighted average price.

From prnewswire.com

Why it matters

Some supportBrind's analysis of the reports

The appointment of a capital markets executive to senior leadership suggests a strategic push for growth and capital formation at Vector Science & Therapeutics Corp. The performance-based stock options granted to Starr tie executive compensation directly to specific stock price milestones.

From prnewswire.com

Who's involved

  • Bill JacksonContinues to serve as Chief Executive Officer of Vector Science & Therapeutics Corp.
  • RUSSELLAppointed President of Vector Science & Therapeutics Corp. and granted performance-based stock options.
  • companyThe company that announced the leadership changes and granted stock options.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped